FFIV vs PPCB · P/E 32, rev $3.09B vs P/E 0.0, $3.9M cap
F5 Networks Inc (FFIV) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. Revenue was up 9.7% from 2024-09-30 to 2025-09-30. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
PPCB does not have a complete income-statement cache yet.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the FFIV and PPCB stock pages for the full models.
Not investment advice.